Medlive Technology Co., Ltd.

2192

KYG5961B1041

Advertising & Marketing

Market Closed - Hong Kong S.E. Other stock markets 04:08:09 2025-06-13 am EDT			5-day change	1st Jan Change
15.18 ^HKD	-8.11%		+5.27%	+53.02%

Mar. 24	Medlive Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
2024	Medlive Technology Co., Ltd. and M3 Enter into the 2024 Renewal Agreement to Extend the Term of the Precision Marketing and Corporate Solutions Services Framework Agreement to 31 December 2027	CI

Medlive Technology Co., Ltd. Proposes Final Dividend for the Year Ended December 31, 2024, Payable on 6 June 2025

Published on 03/24/2025 at 06:40

Medlive Technology Co., Ltd. proposed final dividend of RMB 0.1366 per share for the year ended December 31, 2024. The date of shareholders approval is 8 May 2025. Ex-dividend date is 12 May 2025.

Record date is 16 May 2025. Payment date is 6 June 2025.

Latest news about Medlive Technology Co., Ltd.

Medlive Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024	Mar. 24	CI
Medlive Technology Co., Ltd. and M3 Enter into the 2024 Renewal Agreement to Extend the Term of the Precision Marketing and Corporate Solutions Services Framework Agreement to 31 December 2027	Nov. 11	CI
Medlive Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	24-08-27	CI
Medlive Technology Co., Ltd. Announces Company Secretary Changes	24-07-15	CI
Medlive Technology More than Doubles Profit in 2023	24-04-29	MT
Medlive Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	24-03-25	CI
Medlive Technology to Double Profit in 2023	24-02-28	MT
Medlive Technology Co., Ltd. Provides Earnings Guidance for the Year Ended 31 December 2023	24-02-28	CI
Medlive to Buy 60% of Chinese Pharma Consulting Firm for Some 34 Million Yuan	23-10-13	MT
Medlive Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Medlive Technology to More than Triple H1 Profit	23-08-03	MT
Medlive Technology Co., Ltd. Provides Earnings Guidance for the Six Months Ended 30 June 2023	23-08-03	CI
Medlive Technology Unit to Buy 50% Stake in Beijing SCMedcon	23-06-13	MT
Medlive Technology Co., Ltd. Announces Executive Changes	23-06-12	CI
Medlive Technology Co., Ltd. Announces Director Changes	23-04-14	CI
Medlive Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-23	CI
Medlive Technology's Profit to Rise in 2022	23-03-02	MT
Medlive Technology Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ended 31 December 2022	23-03-02	CI
M3's Fiscal Nine-month Attributable Profit Drops 30% on Increased Operating Costs	23-02-06	MT
Medlive Technology Sees No Explanation For Unusual Share Price Movement	22-12-13	MT
M3's Fiscal H1 Attributable Profit Plunges 41% on High-base Effect	22-11-03	MT
Medlive Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-25	CI
M3's Fiscal Q1 Attributable Profit Tumbles 23% on High-base Effect; Shares Rise 13%	22-07-28	MT
Certain Ordinary Shares of Medlive Technology Co., Ltd. are subject to a Lock-Up Agreement Ending on 14-JUL-2022.	22-07-13	CI
Medlive Technology Buys 60% of Beijing Focus Innovation for $7.2 Million	22-06-08	MT

Chart Medlive Technology Co., Ltd.

Duration

Period

2192: Dynamic Chart

Medlive Technology Co Ltd is a China-based investment holding company mainly operates online professional physician platform. The Company mainly operates three segments. Its Precision Marketing and Corporate Solutions segment provides precision marketing solutions and corporate solutions. Its precision marketing solutions include digital detailing, digital marketing consulting and digital content creation services. Its revenue of its corporate solutions is primarily software as a service (SaaS). The Medical Knowledge Solutions segment mainly provides professional medical information and medical software services. The Intelligent Patient Management Solutions segment mainly provides online patient consultation and prescription services and patient management services. The Company mainly conducts its business within domestic market.

Employees

747

Sector

Advertising & Marketing

Calendar

Aug. 20 - Q2 2025 Earnings Release (Projected)

More about the company